n-acetylglutaminylglutamine amide

N-Acetylglutaminylglutamine amide, as an unusual dipeptide, can be accumulated during osmotic stress in Rhizobium meliloti.

N-Acetylcysteine amide is a thiol antioxidant and neuroprotective agent that can permeate cell membranes and the blood-brain barrier.

C6-Amide-(PEG)n-CH3 (n=310), an active compound utilized for PEGylation in Egaptivon pegol, is a small molecule crucial for researching platelet dysfunction disorders [1].

Val-Cit-amide-Cbz-N(Me)-Maytansine is a molecule that functions both as an antibody and a bispecific antigen-binding entity, targeting the hepatocyte growth factor receptor c-Met (MET), and is used in the formulation of antibody-drug conjugates (ADCs) [1].

N-Acetyl lysyltyrosylcysteine amide acetate is an effective and selective tripeptide inhibitor of myeloperoxidase (MPO). N-Acetyl lysyltyrosylcysteine amide acetate inhibits MPO-dependent hypochlorous acid (HOCl) generation, protein nitration, and LDL ox

N-Acetyl lysyltyrosylcysteine amide is a non-toxic myeloperoxidase (MPO) tripeptide inhibitor that is potent, reversible, and specific.N-Acetyl lysyltyrosylcysteine amide effectively inhibits MPO production in vivo. N-Acetyl lysyltyrosylcysteine amide attenuates neuronal damage and preserves brain tissue and neurological function in the post-stroke brain.N-Acetyl lysyltyrosylcysteine amide inhibits MPO-dependent hypochlorite (HOCl) production, protein nitration and LDL oxidation.N-Acetyl lysyltyrosylcysteine amide is a potent, reversible, and specific agent. N-Acetyl lysyltyrosylcysteine amide is used in the study of bronchial dysplasia.

N-(azide-PEG3)-N'-(Amine-C3-Amide-PEG4)-Cy5 is a polyethylene glycol (PEG)-based linker utilized in PROTAC synthesis [1].

Mal-VC-PAB-(N-Me-amide-C3)-ADU-S100 triethylamine is an immune stimulator antibody conjugate (ISAC) that consists of an anti-human epidermal growth factor receptor 2 (HER2) antibody, a STING agonist (ADU-S100), and a linker, utilized in cancer research.

Anandamide (AEA), an endogenous cannabinoid, interacts with both central (CB1) and peripheral (CB2) cannabinoid receptors. Its effects are concluded through the cellular uptake and enzymatic breakdown of its amide bond by fatty acid amide hydrolase. Arachidonoyl-N-methyl amide, an analog of anandamide, specifically targets the human CB1 receptor, displaying a binding affinity with a Ki of 60 nM. It completely inhibits rat glial gap junction intercellular communication at a concentration of 50 µM.

'(D-Phe5,Cys6,11,N-Me-D-Trp8)-Somatostatin-14 (5-12) amide (Compound 4) is a somatostatin analogue exhibiting varying affinity for somatostatin receptors, with dissociation constants (Kd) of 0.61 nM for SSTR5, 11.05 nM for SSTR3, 23.5 nM for SSTR2, 1200 nM for SSTR1, and >1000 nM for SSTR4, respectively [1].'